Nonsurvival advantages of neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: a patient-level meta-analysis of randomized controlled trials.

Saved in:
Bibliographic Details
Title: Nonsurvival advantages of neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: a patient-level meta-analysis of randomized controlled trials.
Authors: Aliseda, D.1 (AUTHOR), Marti-Cruchaga, P.1 (AUTHOR), Zozaya, G.1 (AUTHOR), Blanco, N.1 (AUTHOR), Ponz, M.2 (AUTHOR), Chopitea, A.2 (AUTHOR), Rodriguez, J.2 (AUTHOR), Castañon, E.2 (AUTHOR), Pardo, F.1 (AUTHOR), Rotellar, F.1 (AUTHOR)
Source: HPB (1365-182X). 2024 Supplement 1, Vol. 26, pS38-S39. 2p.
Database: Academic Search Ultimate
Description
ISSN:1365182X
DOI:10.1016/j.hpb.2024.03.067